课题基金 / 基金详情

Prenatal Diagnosis of Ingenited Metabolic Disorders Using Maternal Blood

Prenatal Diagnosis of Ingenited Metabolic Disorders Using Maternal Blood
利用母血对先天性代谢紊乱进行产前诊断
批准号:
11557061
负责人:
ETO Yoshikatsu
金额:
$7.1万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

ETO Yoshikatsu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prenatal diagnosis by maternal blood is non-invasive manner for mother and fetus. Blood from 3-4 months pregnant mother contain fetal trophoblasts, 1 to 2-30, 000 mother cells. These nucleated erythrocytes exhibit surface antigens such as glycophorin A, CD-71, CD36, Y specific probe and hemoglobin F. Using these markers, we tried to isolate fetal fells using magnetic beads method, lectin method and fluorocytometer methods. We have detected fetal cells and applied to the DNA diagnosis of chromosomal aberrations such as Down syndrome, Aneuploidy syndrome and genetic diseases (Gaucher, Fabry disease)(1) Isolation method of fetal cells from maternal blood :Fctal nucleated cells were isolated from 20 ml pregnant mothers which we obtained informed consent. Using lectin column, magnetic beads column, and fluorocytometry methods, we could isolated fetal nucleated cells. Furthermore, using D18S474 microsatelite marker, we could demonstrated male fetal cells from maternal blood. Furthermore, usi … More ng cDNA micro array method, we tried to study mNA expression in fetal single cells. The results suggest we need more cells to demonstrate.(2) Chromosomal disorders for DNA diagnosis by fetal cells We attempt to demonstrate to give a DNA diagnosis of Down syndrome and aneuploidy syndrome by maternal blood. In order to give a diagnosis these disorders, first we attempted to determine pathogenesis of Aneuploidy syndrome. Several data suggest that This disorder is caused by gene defect in spindle assembly checkpoints.(3) Genetic disorders by DNA diagnosis by fetal cells :We attempted to determine DNA diagnosis in Japanese patients with Gaucher and Fabry disease. We determined the common mutations in Japanese Gaucher disease as follows : L444P, 32%, F2 1 3 I, 17%, D409H, 5.2%, ecNcl, 4.2%. In other hand, Several mutations in Fabry disease from Japanese patients were follows ; L 1 6 H, A37Vm W209X, 342Q, IVS1-1, IVS5-2, IVS5-2, IVS6+1 and etc. These results could be applied for prenatal diagnosis by maternal blood. Less
期刊论文(78)
专著(0)
科研奖励(0)
会议论文
Watabe K, Ida H, Eto Y, et al.: "Establishment and characterization of immortalized Schwann cells from murine moderu of Nieman-Pick disease"J Peripheral Nervous System. 6. 85-94 (2001)
Watabe K、Ida H、Eto Y 等人:“尼曼匹克病小鼠永生化雪旺细胞的建立和表征”J 周围神经系统。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugama S, Kimura SA, Chen W, Kubota S, Seyama Y, Taira N, Eto Y: "Frontal lobe dementia with abnormal cholesterol metaboilsm and heterozygous mutation in sterol 27-hydroxylase gene(CYP27)"J Inherit Metab Dis. 24(3). 379-392 (2001)
Sugama S、Kimura SA、Chen W、Kubota S、Seyama Y、Taira N、Eto Y:“伴有胆固醇代谢异常和甾醇 27-羟化酶基因 (CYP27) 杂合突变的额叶痴呆”J Inherit Metab Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohashi T., Yokoo T., Eto Y., et al.: "Eduction of Lysosomal storage in Murine Mucoplysaccharidosis・・・"Blood. (in press). (2000)
Ohashi T.、Yokoo T.、Eto Y. 等人:“小鼠粘液糖病中溶酶体储存的排出……”血液(2000 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eto Y, Ohashi T: "Gene therapy/ cell therapy for lysosomal strange disease."J Inhert Metab Dis. 23(3). 293-298 (2000)
Eto Y、Ohashi T:“溶酶体奇怪疾病的基因疗法/细胞疗法。”J Inhert Metab Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
38
    Anti-CD3 antibody induced immune tolerance to infused enzyme in enzyme replacement therapy for lysosomal storage disease
    • 批准号:
      21591333
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Immune tolerance induction in enzyme replacement therapy for lysosomal storage diseases
    • 批准号:
      19591223
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Development of novel therapy and elucidation of pathophysiology for genetic leukodystrophy
    • 批准号:
      14370252
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2002
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Molecular Pathogenesis of Brain Damage and Gene Therapy in Genetic Leukodystrophy
    • 批准号:
      11470176
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      1999
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    海外基金